[go: up one dir, main page]

BR0011131A - Sistema de ministração terapêutica transdérmica - Google Patents

Sistema de ministração terapêutica transdérmica

Info

Publication number
BR0011131A
BR0011131A BR0011131-7A BR0011131A BR0011131A BR 0011131 A BR0011131 A BR 0011131A BR 0011131 A BR0011131 A BR 0011131A BR 0011131 A BR0011131 A BR 0011131A
Authority
BR
Brazil
Prior art keywords
transdermal therapeutic
content
present
delivery system
therapeutic delivery
Prior art date
Application number
BR0011131-7A
Other languages
English (en)
Inventor
Stefan Bracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of BR0011131A publication Critical patent/BR0011131A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

"SISTEMA DE MINISTRAçãO TERAPêUTICA TRANSDéRMICA". A presente invenção se refere a um sistema de ministração terapêutica transdérmica incorporada como uma matriz ou sistema de reservatório, caracterizado por: um conteúdo de pelo menos um agente ativo farmacêutico reagente básico ou ativo; e um conteúdo de um polímero adesivo sensível à pressão que possui como parte de seu encadeamento de unidades de ácido acrílico ou ácido metacrílico, o conteúdo de grupos carboxílos relativos à massa média de polímeros, sendo numa quantidade que varia entre 0,5 e 10,0% em peso e os grupos carboxila estando presentes estequiometricamente numa quantidade que varia entre 5 e 100%, preferivelmente 10 e 50% na forma de sais alcalinos ou sais de solo alcalino. Aditivos aderentes à água também podem estar presentes, para reduzir a sensibilidade à umidade.
BR0011131-7A 1999-04-22 2000-04-07 Sistema de ministração terapêutica transdérmica BR0011131A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19918106A DE19918106A1 (de) 1999-04-22 1999-04-22 Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
PCT/EP2000/003112 WO2000064418A2 (de) 1999-04-22 2000-04-07 Transdermales therapeutisches system mit neutralisierten acrylhaftklebern

Publications (1)

Publication Number Publication Date
BR0011131A true BR0011131A (pt) 2003-08-12

Family

ID=7905368

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011131-7A BR0011131A (pt) 1999-04-22 2000-04-07 Sistema de ministração terapêutica transdérmica

Country Status (26)

Country Link
US (1) US6689379B1 (pt)
EP (1) EP1171104B1 (pt)
JP (4) JP2002542277A (pt)
KR (1) KR100693824B1 (pt)
CN (1) CN1204879C (pt)
AR (1) AR023549A1 (pt)
AT (1) ATE364379T1 (pt)
AU (1) AU779960B2 (pt)
BR (1) BR0011131A (pt)
CA (1) CA2370019C (pt)
CZ (1) CZ302169B6 (pt)
DE (2) DE19918106A1 (pt)
DK (1) DK1171104T3 (pt)
ES (1) ES2288851T3 (pt)
HK (1) HK1045264B (pt)
HU (1) HU227693B1 (pt)
IL (2) IL145948A0 (pt)
MX (1) MXPA01010504A (pt)
NZ (1) NZ514946A (pt)
PL (1) PL200815B1 (pt)
PT (1) PT1171104E (pt)
RU (1) RU2242971C2 (pt)
TR (1) TR200102916T2 (pt)
TW (1) TWI275400B (pt)
WO (1) WO2000064418A2 (pt)
ZA (1) ZA200108564B (pt)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
CA2331264C (en) 1999-01-14 2008-09-23 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
JP3935839B2 (ja) * 2000-11-17 2007-06-27 帝三製薬株式会社 エストラジオール含有貼付剤
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE10110391A1 (de) * 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
JP4295467B2 (ja) * 2002-04-12 2009-07-15 日東電工株式会社 貼付剤およびその製造方法
EP1644004A4 (en) 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
US20070077285A1 (en) * 2003-11-21 2007-04-05 Hiroko Udagawa Adhesive skin patch
ITMI20041628A1 (it) * 2004-08-06 2004-11-06 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico transdermico
US20060078602A1 (en) 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Device for transdermal administration of drugs including acrylic polymers
DE102005010255A1 (de) * 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
ITMI20050477A1 (it) * 2005-03-23 2006-09-24 Bouty S P A Cerotto transdermico
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
JP5015562B2 (ja) * 2005-12-13 2012-08-29 日東電工株式会社 貼付製剤
WO2007077741A1 (ja) * 2005-12-28 2007-07-12 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収型製剤
JP5190358B2 (ja) * 2006-02-28 2013-04-24 久光製薬株式会社 経皮吸収型製剤
BRPI0621655A2 (pt) * 2006-05-08 2011-12-20 Teikoku Seiyaku Kk preparação para a absorção percutánea de uma droga antidemência básica
KR100725024B1 (ko) * 2006-06-05 2007-06-07 주식회사 덕성 고흡수성 하이드로콜로이드의 제조방법
JP5192296B2 (ja) * 2007-07-05 2013-05-08 日東電工株式会社 貼付剤および貼付製剤
JP5097034B2 (ja) * 2007-07-20 2012-12-12 日東電工株式会社 貼付剤および貼付製剤
KR100956023B1 (ko) * 2007-09-28 2010-05-06 대화제약 주식회사 산성 관능기를 갖는 아크릴레이트계 고분자의 함량으로약물 방출속도를 제어하는 툴로부테롤 경피 투여용 패취제
JP5209433B2 (ja) * 2007-10-19 2013-06-12 日東電工株式会社 貼付製剤
CA2729346A1 (en) 2008-06-30 2010-01-14 Afgin Pharma, Llc Topical regional neuro-affective therapy
ITMI20081552A1 (it) * 2008-08-29 2010-02-28 Biofarmitalia Spa Composizione migliorata per la trasmissione topica di principi attivi nel corpo umano od animale
KR101738650B1 (ko) * 2009-07-21 2017-05-22 밀란 인크. 폴리이소부틸렌계 경피 패치의 연속 제조 방법
US8221994B2 (en) * 2009-09-30 2012-07-17 Cilag Gmbh International Adhesive composition for use in an immunosensor
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
ES2670227T3 (es) * 2009-12-22 2018-05-29 Luye Pharma Ag Sistema terapéutico transdérmico para la administración de rivastigmina o sus derivados
AU2011248904B2 (en) 2010-04-30 2014-02-27 Teikoku Seiyaku Co., Ltd. Propynylaminoindan transdermal compositions
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
CN102559110A (zh) * 2010-12-09 2012-07-11 湖北航天化学技术研究所 乳液型有机硅改性丙烯酸酯压敏胶及其制备方法和应用
EP2468274B1 (de) 2010-12-14 2015-07-01 Acino AG Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs
KR101853082B1 (ko) 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
CN103796645B (zh) * 2011-08-31 2017-06-20 东洋油墨Sc控股株式会社 贴剂
WO2013047410A1 (ja) * 2011-09-28 2013-04-04 ニチバン株式会社 持続型アルツハイマー病治療用貼付剤及びその製造方法
WO2013070526A1 (en) 2011-11-09 2013-05-16 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
US10470936B2 (en) 2012-02-29 2019-11-12 Hollister Incorporated Buffered adhesive compositions for skin-adhering medical products
AU2013226154B2 (en) * 2012-02-29 2015-07-09 Hollister Incorporated Buffered adhesive compositions for skin-adhering products and methods of making same
WO2013187451A1 (ja) * 2012-06-12 2013-12-19 株式会社 ケイ・エム トランスダーム 貼付剤
CA2883930A1 (en) * 2012-09-03 2014-03-06 Nipro Patch Co., Ltd. Adhesive skin patch
WO2014051128A1 (ja) * 2012-09-28 2014-04-03 株式会社 ケイ・エム トランスダーム 貼付剤
CN104797245B (zh) 2012-11-02 2018-05-04 帝国制药美国公司 丙炔基氨基茚满透皮组合物
JP6391664B2 (ja) * 2013-03-15 2018-09-19 エヌエーエル ファーマスーティカル グループ リミテッド リバスチグミンを含む、経皮薬物送達システム
EP3718544A1 (en) * 2013-10-01 2020-10-07 Novartis AG Combination
KR101827980B1 (ko) * 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
JP6310070B2 (ja) * 2013-10-07 2018-04-11 テイコク ファーマ ユーエスエー インコーポレーテッド デクスメデトミジン経皮組成物を用いる、注意欠陥多動性障害、不安症及び不眠症の治療法及び組成物
US10987342B2 (en) 2013-10-07 2021-04-27 Teikoku Pharma Usa, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
CN106413695B (zh) * 2014-04-08 2019-12-10 帝国制药美国公司 利伐斯的明透皮组合物及其使用方法
RU2723761C1 (ru) 2016-10-31 2020-06-17 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы устранения боли с использованием устройств для трансдермальной доставки дексмедетомидина
CN106634704A (zh) * 2016-12-08 2017-05-10 苏州艾博迈尔新材料有限公司 一种抗过敏医用压敏胶及其制备工艺
MX382132B (es) 2016-12-20 2025-03-13 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno
KR102506333B1 (ko) 2016-12-20 2023-03-06 에르테에스 로만 테라피-시스테메 아게 아세나핀을 함유하는 경피흡수 치료 시스템
CN110799180A (zh) 2017-06-26 2020-02-14 罗曼治疗系统股份公司 含阿塞那平和硅氧烷丙烯酸杂化聚合物的经皮治疗系统
CN107320463A (zh) * 2017-07-10 2017-11-07 徐静 一种含有单硝酸异山梨酯的缓释透皮贴剂及其应用
WO2019068288A1 (de) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung
JP7220473B2 (ja) * 2017-10-30 2023-02-10 帝國製薬株式会社 経皮投与製剤
PL3810100T3 (pl) 2018-06-20 2025-05-12 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny zawierający asenapinę
WO2019243432A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
US11752114B2 (en) * 2019-04-17 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
CA3156257A1 (en) 2019-10-03 2021-04-08 Starton Therapeutics, Inc. TRANSDERMAL DELIVERY OF DRONABINOL
US12409131B2 (en) 2019-10-03 2025-09-09 Pike Therapeutics Usa, Inc. Transdermal delivery of dronabinol
US12016829B2 (en) * 2019-10-11 2024-06-25 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders
EP4041209A4 (en) 2019-10-11 2024-01-24 Pike Therapeutics, Inc. TRANSDERMAL COMPOSITIONS COMPRISING CANNABIDIOL (CBD) FOR USE IN THE TREATMENT OF EPILEPTIC DISORDERS

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE279611C (pt)
JPS5259636A (en) 1975-11-11 1977-05-17 Soken Kagaku Kk Composition of pressure sensitive adhesive
DD279611A1 (de) * 1985-03-07 1990-06-13 Univ Ernst Moritz Arndt Verfahren zur herstellung einer haftarzneiform
EP0223524B1 (en) * 1985-11-08 1991-10-23 Nitto Denko Corporation Use of adhesive dermal bandages and dermal percutaneous preparations
JP2632838B2 (ja) * 1986-10-23 1997-07-23 久光製薬 株式会社 外用貼付剤
JPS63137746A (ja) * 1986-12-01 1988-06-09 Lion Corp マイクロカプセル及びその製造方法
EP0387751B1 (en) * 1989-03-15 1994-06-08 Nitto Denko Corporation Medicated plasters
JP2693212B2 (ja) * 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
DE3913734C2 (de) * 1989-04-26 1998-08-20 Roehm Gmbh Verwendung einer wäßrigen Hauthaftkleberlösung zur Herstellung einer mit Wasser leicht abwaschbaren Klebschicht
JP3046346B2 (ja) * 1990-03-12 2000-05-29 昭和電工株式会社 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
JP3308593B2 (ja) * 1992-06-19 2002-07-29 日東電工株式会社 機能性外用材及びその製造方法
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
JPH06346041A (ja) * 1993-06-10 1994-12-20 Showa Denko Kk 親水性粘着剤組成物
CA2117546A1 (en) * 1993-08-27 1995-02-28 Takateru Muraoka Medical adhesive sheet
JP3451125B2 (ja) * 1993-12-27 2003-09-29 ニチバン株式会社 粘着テープ及びその製造方法
JPH07206710A (ja) * 1994-01-21 1995-08-08 Nitto Denko Corp 経皮投薬用テープ製剤
EP0743842B1 (en) * 1994-03-07 2003-08-13 Theratech, Inc. Drug-containing adhesive composite transdermal delivery device
FR2717689B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base de copolymère styrène-isoprène-styrène.
JPH07330602A (ja) * 1994-06-13 1995-12-19 Nitto Denko Corp 経皮吸収型ピロカルピン製剤
DE4423850A1 (de) * 1994-07-07 1996-01-11 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Naloxon
DE4429791C2 (de) * 1994-08-23 1997-04-24 Lohmann Therapie Syst Lts Medizinischer Haftkleber auf Basis von Polyacrylaten und dessen Verwendung
JP3361674B2 (ja) * 1995-11-08 2003-01-07 日本カーバイド工業株式会社 医療用粘着剤組成物
JPH09143061A (ja) * 1995-11-20 1997-06-03 Showa Denko Kk 鎮痛剤用経皮吸収製剤
JP3497309B2 (ja) * 1995-12-22 2004-02-16 積水化学工業株式会社 貼付剤
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
JPH10316590A (ja) * 1997-05-14 1998-12-02 Showa Denko Kk 局所麻酔用外用剤
DE19728516C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Levonorgestrel und gegebenenfalls Estradiol
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
KR100693824B1 (ko) 2007-03-12
PL352550A1 (en) 2003-08-25
DK1171104T3 (da) 2007-10-15
KR20010112452A (ko) 2001-12-20
HU227693B1 (en) 2011-12-28
AU4294200A (en) 2000-11-10
PL200815B1 (pl) 2009-02-27
PT1171104E (pt) 2007-09-21
AR023549A1 (es) 2002-09-04
CA2370019A1 (en) 2000-11-02
AU779960B2 (en) 2005-02-24
JP2015108007A (ja) 2015-06-11
JP2013082727A (ja) 2013-05-09
US6689379B1 (en) 2004-02-10
ES2288851T3 (es) 2008-02-01
JP2009051840A (ja) 2009-03-12
MXPA01010504A (es) 2002-06-04
NZ514946A (en) 2004-02-27
CZ302169B6 (cs) 2010-11-24
EP1171104A2 (de) 2002-01-16
ZA200108564B (en) 2002-09-11
JP5719500B2 (ja) 2015-05-20
IL145948A (en) 2006-10-31
IL145948A0 (en) 2002-07-25
CA2370019C (en) 2010-06-08
HK1045264A1 (en) 2002-11-22
ATE364379T1 (de) 2007-07-15
EP1171104B1 (de) 2007-06-13
WO2000064418A3 (de) 2001-03-15
CN1354654A (zh) 2002-06-19
WO2000064418A2 (de) 2000-11-02
HUP0200635A2 (hu) 2002-07-29
TR200102916T2 (tr) 2002-01-21
RU2242971C2 (ru) 2004-12-27
JP2002542277A (ja) 2002-12-10
CZ20013763A3 (cs) 2002-02-13
HUP0200635A3 (en) 2006-07-28
TWI275400B (en) 2007-03-11
JP6170082B2 (ja) 2017-07-26
HK1045264B (zh) 2005-09-16
CN1204879C (zh) 2005-06-08
DE50014413D1 (de) 2007-07-26
DE19918106A1 (de) 2000-10-26

Similar Documents

Publication Publication Date Title
BR0011131A (pt) Sistema de ministração terapêutica transdérmica
Buzalaf et al. Role of host-derived proteinases in dentine caries and erosion
EP0072251B1 (en) Improved bandage containing a medicament
ATE245450T1 (de) Haftende mikrokügelchen umfassende zusammensetzung zur arzneimittelgabe
BR9712806A (pt) Emplastro de matriz adesiva sensìvel à pressão para liberação transdérmica de sais de agentes farmacêuticos
ES2196055T3 (es) Dispositivo transdermico que contiene polivinilpirrolidona como intensificador de la solubilidad.
BR0312988A (pt) Microcápsulas com liberação modificada de princìpios ativos pouco solúveis para a administração per os
BR9806747A (pt) Sistema terapêutico transdérmico.
BR9904742A (pt) Patch, conjunto constituìdo por um patch e por um recipiente, e processo
ATE202476T1 (de) Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
ATE286715T1 (de) Gastrointestinale an der mucosa haftende pharmazeutische zusammensetzung
BRPI0822162B8 (pt) composição farmacêutica para tratamento tópico de doença das unhas ou leito ungueal
DE60334924D1 (de) Anoteilchengrösse
BRPI0410584A (pt) estrutura absorvente de lìquido flexìvel
AR038575A1 (es) Formulacion oftalmica con nueva composicion de goma
World Health Organization The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2018 (StemBook2018)
BR0014946A (pt) Uso de dipiridamol ou mopidamol na fabricação de um medicamento para o tratamento e prevenção de distúrbios da microcirculação dependentes da fibrina
KR850700218A (ko) 약학 조성물
PE17897A1 (es) Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano
ES2097845T3 (es) Material de gel acrilico y preparacion medica a base de gel para absorcion percutanea mediante el empleo del mismo.
PE20001496A1 (es) Formulacion de liberacion controlada para el tratamiento de epoc
BR9916910A (pt) Fita de correção
BRPI0417530B8 (pt) composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit
BRPI0011135B8 (pt) sistema de ministração terapêutica transdérmica contendo agente neuroléptico

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15Z Prolongation of time limit refused

Free format text: NEGADA A SOLICITACAO DE DEVOLUCAO DE PRAZO UMA VEZ QUE NAO FICOU COMPROVADA A JUSTA CAUSA CONFORMEDEFINIDA NO ART. 221 DA LPI.

B12F Other appeals [chapter 12.6 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.